Clinical pharmacology of targeted treatments


E-session 502

Expert
Markus Jörger'
Cantonal Hospital
St.Gallen, Switzerland
Discussant
Alwin Huitema'
Netherlands Cancer Institute
Amsterdam, The Netherlands

This e-Session is part of the following pathway(s):
31
Oct 2019